From the American Association for Cancer Research news releases:
The more advanced (available) of the 2 new makers is for chemo effectiveness & is called OncoPlanTM :
http://www.aacr.org/Default.aspx?p=1066&d=653
Test Helps Identify Patients with Breast Cancer Who Will Likely Benefit from Chemotherapy, and Those Who Won’t
September 15, 2006
The second marker is for effectiveness of antiangiogenesis treatments ( such as Avastin) & is still in research & development:
http://www.aacr.org/Default.aspx?p=1275&d=654
Potential Diagnostic Marker Indicates Effectiveness of Anti-angiogenic Drugs
September 15, 2006
Linear Mode
